
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 46.070 | 46.090 | 0.020 |
Stocks | 54.200 | 54.200 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 25.194 | 13.206 |
Price to Book | 2.212 | 1.475 |
Price to Sales | 2.053 | 0.840 |
Price to Cash Flow | 16.137 | 7.861 |
Dividend Yield | 1.388 | 2.131 |
5 Years Earnings Growth | 12.452 | 14.199 |
Name | Net % | Category Average |
---|---|---|
Technology | 37.710 | 19.922 |
Communication Services | 24.830 | 5.356 |
Healthcare | 17.300 | 6.755 |
Industrials | 11.610 | 25.988 |
Consumer Cyclical | 5.930 | 17.065 |
Basic Materials | 2.620 | 8.939 |
Number of long holdings: 30
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
United States Treasury Bills | - | 21.61 | - | - | |
United States Treasury Bills | - | 16.60 | - | - | |
Advantest Corp. | JP3122400009 | 7.94 | 6,443.0 | +2.55% | |
SoftBank Group Corp. | JP3436100006 | 6.16 | 7,465.0 | -0.37% | |
Tokyo Electron | JP3571400005 | 5.43 | 20,640.0 | +1.93% | |
KDDI Corp. | JP3496400007 | 4.53 | 2,327.0 | -1.04% | |
TDK | JP3538800008 | 4.48 | 1,533.5 | +1.39% | |
Recruit Holdings | JP3970300004 | 2.76 | 8,094.0 | +3.89% | |
Chugai Pharmaceutical | JP3519400000 | 2.32 | 6,585.0 | -2.99% | |
Terumo Corp. | JP3546800008 | 2.16 | 2,746.5 | -0.83% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IL0051274699 | 1.51B | -2.46 | 16.13 | - | ||
PTF Nasdaq 100 | 768.66M | -4.33 | 18.21 | - | ||
PTF TA-125 | 655.66M | 4.76 | 7.37 | 6.63 | ||
Psagot Managed TA 125 | 655.25M | 5.83 | 7.31 | 9.57 | ||
IL0051341688 | 574.13M | 9.74 | 15.58 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review